Page 3 - Mdna News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mdna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mdna Today - Breaking & Trending Today

Letko Brosseau & Associates Inc. Grows Stock Holdings in Medicenna Therapeutics Corp. (NASDAQ:MDNA)

Letko Brosseau & Associates Inc. increased its stake in shares of Medicenna Therapeutics Corp. (NASDAQ:MDNA – Get Rating) by 70.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 170,000 shares of the company’s stock after buying an additional 70,000 shares during […] ....

Annandale Capital , Letko Brosseau Associates Inc , Rathbones Group Plc , Sigma Planning Corp , Medicenna Therapeutics Corp , Maven Securities , Securities Exchange Commission , Letko Brosseau , Medicenna Therapeutics , Get Rating , Group Plc , Planning Corp , Empowered Cytokines , Fahar Merchant , Rosemina Merchant , Visit Holdingschannel , Medicenna Therapeutics Daily , Nasdaq Mdna , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Medicenna Therapeutics (NASDAQ:MDNA) Trading Down 1.8%

Medicenna Therapeutics Corp. (NASDAQ:MDNA – Get Rating)’s stock price dropped 1.8% during mid-day trading on Thursday . The stock traded as low as $0.74 and last traded at $0.74. Approximately 70,588 shares were traded during mid-day trading, a decline of 30% from the average daily volume of 100,742 shares. The stock had previously closed at […] ....

Rathbones Group Plc , Annandale Capital , Letko Brosseau Associates Inc , Renaissance Technologies , Medicenna Therapeutics Corp , Millennium Management , Medicenna Therapeutics , Get Rating , Therapeutics Trading Down , Group Plc , Empowered Cytokines , Fahar Merchant , Rosemina Merchant , Medicenna Therapeutics Daily , Nasdaq Mdna ,

Medicenna Therapeutics (NASDAQ:MDNA) Trading Down 1.8%

Medicenna Therapeutics Corp. (NASDAQ:MDNA – Get Rating) was down 1.8% on Thursday . The company traded as low as $0.74 and last traded at $0.74. Approximately 70,588 shares were traded during trading, a decline of 30% from the average daily volume of 100,742 shares. The stock had previously closed at $0.76. Analyst Ratings Changes Separately, […] ....

Medicenna Therapeutics Corp , Millennium Management , Letko Brosseau Associates Inc , Renaissance Technologies , Capital Management , Sigma Planning Corp , Medicenna Therapeutics Company Profile , Medicenna Therapeutics , Get Rating , Therapeutics Stock Down , Planning Corp , Empowered Cytokines , Fahar Merchant , Rosemina Merchant , Medicenna Therapeutics Daily , Nasdaq Mdna ,

Medicenna Therapeutics (TSE:MDNA) Stock Price Up 1%

Shares of Medicenna Therapeutics Corp. (TSE:MDNA – Get Rating) rose 1% during mid-day trading on Tuesday . The company traded as high as C$1.03 and last traded at C$1.02. Approximately 2,901 shares traded hands during trading, a decline of 87% from the average daily volume of 23,197 shares. The stock had previously closed at C$1.01. […] ....

Medicenna Therapeutics Corp , Medicenna Therapeutics , Get Rating , Therapeutics Corp , Medicenna Therapeutics Daily , Tse Mdna ,

Medicenna Therapeutics (TSE:MDNA) Trading 2.6% Higher

Shares of Medicenna Therapeutics Corp. (TSE:MDNA – Get Rating) traded up 2.6% during mid-day trading on Monday . The stock traded as high as C$0.80 and last traded at C$0.80. 10,051 shares were traded during trading, a decline of 56% from the average session volume of 22,920 shares. The stock had previously closed at C$0.78. […] ....

Medicenna Therapeutics Corp , Medicenna Therapeutics , Get Rating , Therapeutics Corp , Medicenna Therapeutics Daily , Tse Mdna ,